In focus · trending topic

Silvia Taylor

2 stories · following the connections

Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with Priority Review Designation

By Nasdaq OMXSep 28, 2017, 9:34 PM UTC

Sucampo Acquires Vtesse Inc.

By Nasdaq OMXApr 3, 2017, 10:30 AM UTC